Source:http://linkedlifedata.com/resource/pubmed/id/18783939
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
16
|
| pubmed:dateCreated |
2008-10-30
|
| pubmed:abstractText |
Renal cell carcinoma (RCC) is the sixth leading cause of death in developed countries. A third of all RCC patients are confronted with metastatic disease. Since their approval in 2005 and 2006 in the USA, new targeted therapies may lead to substantial progress. Thus, the aim of this cohort study was to present clinical characteristics and survival in metastatic RCC in a population-based sample before widespread implementation of these new therapies.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
Nov
|
| pubmed:issn |
1879-0852
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
44
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
2485-95
|
| pubmed:meshHeading |
pubmed-meshheading:18783939-Adult,
pubmed-meshheading:18783939-Age of Onset,
pubmed-meshheading:18783939-Aged,
pubmed-meshheading:18783939-Aged, 80 and over,
pubmed-meshheading:18783939-Carcinoma, Renal Cell,
pubmed-meshheading:18783939-Female,
pubmed-meshheading:18783939-Follow-Up Studies,
pubmed-meshheading:18783939-Germany,
pubmed-meshheading:18783939-Humans,
pubmed-meshheading:18783939-Kidney Neoplasms,
pubmed-meshheading:18783939-Male,
pubmed-meshheading:18783939-Middle Aged,
pubmed-meshheading:18783939-Survival Rate
|
| pubmed:year |
2008
|
| pubmed:articleTitle |
Metastatic renal cell carcinoma: results of a population-based study with 25 years follow-up.
|
| pubmed:affiliation |
Munich Cancer Registry (MCR) of the Munich Cancer Centre (MCC), Department of Medical Informatics, Biometrics and Epidemiology (IBE), Ludwig-Maximilians-Universität, Munich, Germany. schlesi@ibe.med.uni-muenchen.de
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|